Streetbeat News

Stock Prices

INTA

Intapp (NASDAQ:INTA) has received varied analyst ratings, with most being bullish. Recent evaluations show an increase in average price targets, indicating positive sentiment. Intapp's financial performance includes a 20.88% revenue growth and a strong net margin, though its ROE is below industry averages.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 1:01 pm

DKNG

DraftKings (NASDAQ:DKNG) has received 32 analyst ratings over the past three months, with a majority being bullish. The average 12-month price target is $52.34, a slight decline from previous estimates. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. DraftKings shows strong financial performance with significant revenue growth, high net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 1:00 pm

NAMS

NewAmsterdam Pharma (NASDAQ:NAMS) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. Analysts have set a 12-month price target range of $31.00 to $37.00, with an average of $33.75, slightly up from the previous $33.00. The company shows strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 1:00 pm

KVUE

Kenvue (NYSE:KVUE), the world's largest pure-play consumer health company, has received diverse analyst ratings ranging from bullish to indifferent. Recent analyst actions include raising and lowering price targets, with an average 12-month target of $22.5. Despite a slight revenue decline, Kenvue shows strong financial health with high net margins and ROE.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 1:00 pm

AMD

AMZN

FTXL

GOOGL

NVDA

SEMI

AMD's CEO Lisa Su predicts a shift in AI chip demand from GPUs to custom chips, highlighting potential benefits in energy efficiency and cost. This could impact companies like Nvidia, Amazon, and Google, who are currently leading in AI chip development.

Portfolio Pulse from Anusuya Lahiri

September 23, 2024 | 12:59 pm

KRON

Kronos Bio presented preclinical data at the AACR Symposium showing the efficacy of Istisociclib in treating advanced ovarian cancer, particularly in models resistant to platinum and PARP inhibitors.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:56 pm

OTRK

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update may involve OTRK, suggesting potential news or developments related to the company.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:55 pm

BCDF

IAI

NDAQ

Nasdaq, Inc. (NASDAQ:NDAQ) is expanding its digital banking technology operations in Latin America by supplying Nubank with its AxiomSL regulatory reporting solution. This move strengthens Nasdaq's presence in the region and highlights the growing demand for financial technology solutions. Nasdaq serves over 50 banking clients in Latin America and is focusing on supporting the rapid expansion of digital banking. The company recently unveiled a new leadership structure to support its growth. Investors can gain exposure to Nasdaq through ETFs like BCDF and IAI.

Portfolio Pulse from Lekha Gupta

September 23, 2024 | 12:52 pm

GM

TSLA

GM CEO Mary Barra reaffirms the company's goal to sell only electric light-duty vehicles by 2035, despite a slowdown in EV demand. GM sold 21,930 EVs in Q2, lagging behind Tesla's 164,264 units. GM plans to expand its EV lineup, including the Cadillac Escalade IQ and next-gen Chevrolet Bolt EV.

Portfolio Pulse from Anan Ashraf

September 23, 2024 | 12:51 pm

ELAB

Elevai Labs' stock is trading lower following the announcement of an $8.0 million public offering. This move may dilute existing shares, leading to a decrease in stock price.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:49 pm